JAVELIN

Serial Number 78158315
606

Registration Progress

Application Filed
Aug 27, 2002
Under Examination
Dec 2, 2003
Approved for Publication
Aug 20, 2003
Published for Opposition
Sep 9, 2003
Registered

Basic Information

Serial Number
78158315
Filing Date
August 27, 2002
Published for Opposition
September 9, 2003
Abandonment Date
June 3, 2006
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jun 3, 2006
Classes
042

Rights Holder

ANTIGENICS INC.

03
Address
630 FIFTH AVENUE
NEW YORK, NY 10111

Ownership History

Mojave Therapeutics, Inc.

Original Applicant
03
Hawthorne, NY

Mojave Therapeutics, Inc.

Owner at Publication
03
Hawthorne, NY

ANTIGENICS INC.

New Owner After Publication #1
03
NEW YORK, NY

Legal Representation

Attorney
Ilene B Tannen

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

25 events
Date Code Type Description
Aug 10, 2006 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Aug 10, 2006 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Dec 30, 2005 EX4G S SOU EXTENSION 4 GRANTED
Dec 5, 2005 MAIL I PAPER RECEIVED
Dec 2, 2005 EXT4 S SOU EXTENSION 4 FILED
Jun 14, 2005 EX3G S SOU EXTENSION 3 GRANTED
Jun 1, 2005 MAIL I PAPER RECEIVED
Jun 1, 2005 EXT3 S SOU EXTENSION 3 FILED
May 26, 2005 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 22, 2004 EX2G S SOU EXTENSION 2 GRANTED
Dec 21, 2004 MAIL I PAPER RECEIVED
Dec 6, 2004 MAIL I PAPER RECEIVED
Dec 2, 2004 EXT2 S SOU EXTENSION 2 FILED
Apr 22, 2004 EX1G S SOU EXTENSION 1 GRANTED
Apr 20, 2004 CFIT O CASE FILE IN TICRS
Apr 8, 2004 MAIL I PAPER RECEIVED
Apr 5, 2004 EXT1 S SOU EXTENSION 1 FILED
Dec 2, 2003 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT
Sep 9, 2003 PUBO A PUBLISHED FOR OPPOSITION
Aug 20, 2003 NPUB O NOTICE OF PUBLICATION
Jul 16, 2003 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 23, 2003 MAIL I PAPER RECEIVED
Jun 23, 2003 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 27, 2003 GNRT F NON-FINAL ACTION E-MAILED
Jan 22, 2003 DOCK D ASSIGNED TO EXAMINER

Detailed Classifications

Class 042
BIOPHARMACEUTICAL DRUG DEVELOPMENT SERVICES
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
042